A machine learning-driven framework accurately predicts MPA exposure and supports individualized dosing in childhood-onset LN.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results